Clinical trial
Efficacy, Safety, and Tolerability of GRT6005 in Subjects With Moderate to Severe Chronic Low Back Pain.
NCT01725087 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety, and Tolerability of GRT6005 in Subjects With Moderate to Severe Chronic Low Back Pain.
- Lead sponsor
- Tris Pharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- July 31, 2014
- Enrollment
- 1,089 (actual)
- Sites
- 79
Conditions
As the registry lists them; a condition with its own page is linked.